Treatment of rheumatoid arthritis with IL-1 inhibitors

Springer Seminars in Immunopathology

Volumn 20, Issue 1-2, 1998, Pages 229-246

  Gabay, Cem ^a   Arend, William P ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ARTICLE; CLINICAL TRIAL; GENE THERAPY; INFLAMMATION; JOINT DESTRUCTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0031786230     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00832009     Document Type: Article

References (90)

1. Akeson AL, Woods CW, Hsieh LC, Bohnke RA, Ackermann BL, Chan KY, Robinson JL, Yanofsky SD, Jacob JW, Barrett RW, Bowlin TL (1996) AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1. J Biol Chem 271:30517
2. Allen JB, Wong HL, Costa GL, Bienkowski MJ, Wahl SM (1993) Suppression of monocyte function and differential regulation of IL-1 and IL-1Ra by IL-4 contribute to resolution of experimental arthritis. J Immunol 151: 4344
3. Angel P, Karin M (1991) The role of Jun. Fos and AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072:129
4. Arend WP ( 1993) Interleukin-1 receptor antagonist. Adv Immunol 54:167
5. Arend WP, Payer J-M (1995) Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 38: 151
6. Arend WP, Welgus HG, Thompson RC, Eisenberg SP (1990) Biological properties of recombinant monocyte-derived interleukin I receptor antagonist. J Clin Invest 85:1694
7. Arend WP, Malyak M, Smith MF Jr, Whisenand TD, Slack JL, Sims JE, Giri JG, Dower SK (1994) Binding of IL-1α, IL-1β, and IL-1 receptor anlagonisl by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J Immunol 153:4766
8. Arner EC, Harris RR, DiMeo TM, Collins RC, Galbraith W (1995) Interleukin-1 receptor antagonist inhibits proteoglycan breakdown in antigen induced but not in polycation induced arthritis in the rabbit. J Rheumatol 22: 1338
9. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286
10. Baeuerle PA, Baichwal VR (1997) NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol 65:111
11. Bakker AC, Joosten LAB, Arntz OJ, Helsen MMA, Bendele AM, Loo FAJ van de, Berg WB van den (1997) Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheum 40:893
12. Bandara G, Mueller GM, Galea-Lauri J, Tindal MH, Georgescu HI, Suchanek MK, Hung GL, Glorioso JC, Robbins PD, Evans CH (1993 ) Intraarticular expression of biologically active interleukin 1 receptor antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci USA 90:10764
13. Baragi VM, Renkiewiez RR, Jordan H, Bonadio J, Hartman JW, Roessler BJ (1995) Transplantation of transduced chondrocytes protects articular cartilage from interleukin-1-induced extracellular matrix degradation. J Clin Invest 96:2454
14. Bendele AM, Sennello G, McAbee T, Frazier J, Chlipala E (1997) Effects of interleukin-1 receptor antagonist alone and in combination with methotrexate in adjuvant arthritic rats. Arthritis Rheum 40:S181
15. Bessis N, Boissier MC, Ferrara P, Blankenstein T, Fradelizi D (1996) Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur J Immunol 26:2399
16. Boggs SS, Patrene KD, Mueller GM, Evans CH, Doughty LA, Robbins PD (1995) Prolonged systemic-expression of human IL-1 receptor antagonist (hIL-1ra) in mice reconstituted with hematopoietic cells transduced with a retrovirus carrying the h1L-1ra cDNA. Gene Therapy 2:632
17. Bresnihan B, Alvaro-Gracia JM, Cobby M, Doherty M, Domljan Z, Emery P, Nuki G, Pavelka K, Rau R, Rozman B, Watt I, Williams B, Aitchison R, McCabe D, Musikic P (1998) Treatment of rheumatoid arthritis with recombinant human inlerleukin-1 receptor antagonist. Arthritis Rheum (in press)
18. Brown EA, Dare HA, Marsh CB, Wewers MD (1996) The combination of endotoxin and dexamethasone induces type II interleukin I receptor (IL-1r II) in monocytes: a comparison Io inlerleukin 1β (IL-1β) and interleukin 1 receptor antagonist (IL-1ra). Cytokine 8:828
19. Burger D, Chicheportiche R, Giri JG, Dayer J-M (1995) The inhibitory activity of human interleukin-1 reeeplor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor. J Clin Invest 96:38
20. Campion GV, Lebsack ME, Lookabaugh J, Gordon G, Catalano MA (1996) Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 39:1092
21. Caron JP, Fernandes JC, Martel-Pelletier J, tardif G, Mineau F, Geng C, Pelletier J-P (1996) Chondroproteetive effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression. Arthritis Rheum 39:1535
22. Chernoff AE, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB, Kennedy JS, Rabson AR, Wolff SM, Dinarello CA (1995) A randomized, controlled trial of interleukin-10 in humans: inhibition of inflammatory cytokine production and immune responses. J Immunol 154:5492
23. Chikanza IC, Roux-Lombard P, Dayer J-M, Panayi G (1995) Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 38:642
24. Collins D, McAbee T, Woodward M, Frazier J, Chlipala E, Bendele A (1997) A slow release formulation of interleukin-1 receptor antagonist (IL-1Ra) exhibits improved in vivo activity. Arthritis Rheum 40: S180
25. Colotta F, Dower SK, Sims JE, Mantovani A (1994) The type II "decoy" receptor: a novel regulatory pathway for interleukin 1. Immunol Today 15:562
26. Conner EM, Fuseler JW, Davis JM, Laroux FS, Palombella VJ, Brand S, Wolf RE, Grisham MB (1997) Selective proteasome inhibition attenuates experimental polyarthritis via inhibition of nuclear transcription factor κB (NFκB) activation. Arthritis Rheum 40:S322
27. De Waal Malefyt R, Figdor CG, Huijbens R, Mohan-Peterson S, Benett B, Culpepper J, Dang W, Zurawski G, De Vries JE (1993) Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFNγ or IL-10. J Immunol 151: 6370
28. Deleuran BW, Chu CQ, Field M, Brennan FM, Katsikis P, Feldmann M, Maini RN (1992) Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. Br J Rheumatol 31:801
29. Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87:2095
30. Donnelly RP, Crofford LJ, Freeman SL, Buras J, Remmers E, Wilder RL, Fenton MJ (1993) Tissue-specific regulation of IL-6 production by IL-4. Differential effects of IL-4 on nuclear factor-κB activity in monocytes and fibroblasts. J Immunol 151:5603
31. Dower SK, Fanslow W, Jacobs C, Waugh S, Sims JE, Widmer MB (1994) Interleukin-1 antagonists. Ther Immunol 1:113
32. Drevlow BE, Lovis R, Haag MA, Sinacore JM, Jacobs C, Blosche C, Landay A, Moreland LW, Pope RM (1996) Recombinant human interleukin-1 receptor type I in the treatment of patients with active rheumatoid arthritis. Arthritis Rheum 39:257
33. Eisenberg SP, Brewer MT, Verderber E, Heimdal P, Brandhuber BJ, Thompson RC (1991) Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism. Proc Natl Acad Sci USA 88:5232
34. Fantuzzi G, Ku G, Harding MW, Livingston DJ, Sipe JD, Kuida K, Flavell RA, Dinarello CA (1997) Response to local inflammation of IL-1 beta-converting enzyme-deficient mice. J Immunol 158:1818
35. Firestein GS, Berger AE, Tracey DE, Chosay JG, Chapman DL, Paine MM, Yu C, Zvaifler NJ (1992) IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium. J Immunol 149:1054
36. Firestein GS, Boyle DL, Yu C, Paine MM, Whisenand TD, Zvaifler NJ, Arend WP (1994) Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 37: 644
37. Fukumoto T, Matsukawa A, Ohkawara S, Takagi K, Yoshinaga M (1996) Administration of neutralizing antibody against rabbit IL-1 receptor antagonist exacerbates lipopolysaccharide-induced arthritis in rabbits. Inflamm Res 45:479
38. Gabay C, Smith MF Jr, Eidlen D, Arend WP (1997) Interleukin-1 receptor antagonist is an acute-phase protein. J Clin Invest 99:2930
39. Ghivizzani SC, Kang R, Muzzonigro T, Whalen J, Walkins SC, Herndon JH, Robbins PD, Evans CH (1997) Gene therapy for arthritis - treatment of the first three patients. Arthritis Rheum 40:S223
40. Handel ML, McMorrow LB, Gravallese EM (1995) Nuclear factor-κB in rheumatoid synovium. Localization of p50 and p65. Arthritis Rheum 38:1762
41. Hauselmann HJ, Flechtenmacher J, Michal L, Thonar EJ-MA, Shinmei M, Kuettner KE, Aydelotte MB (1996) The superficial layer of human articular cartilage is more susceptible to interleukin-1-induced damage than the deeper layers. Arthritis Rheum 39:478
42. Henderson B, Thompson RC, Hardingham T, Lewthwaite J (1991) Inhibition of interleukin-1-induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant interleukin-1 receptor antagonist. Cytokine 3:246
43. Hirsch E, Irikura VM, Paul SM, Hirsh D (1996) Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci USA 93:11008
44. Joosten LAB, Lubberts E, Durez P, Helsen MMA, Jacobs MJM, Goldman M, Berg WB van den (1997) Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Arthritis Rheum 40:249
45. Kremer JM, Lawrence DA, Petrillo GF, Litts LL, Mullaly PM, Rynes RI, stocker RP, Parhami N, Greenstein NS, Fuchs BR, Mathur A, Robinson DR, Sperling RI, Bigaouette J (1995) Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Arthritis Rheum 38:1107
46. Ku G, Faust T, Lauffer LL, Livingston DJ, Harding MW (1996) Interleukin-1β converting enzyme inhibition blocks progression of type II collagen-induced arthritis in mice. Cytokine 8:377
47. Kuroki Y, Shiozawa S, Sugimoto T, Kanatani M, Kaji H, Miyauchi A, Chihara K (1994) Constitutive c-fos expression in osteoblastic MC3T3-E1 cells stimulates osteoclast maturation and osteoclastic bone resorption. Clin Exp Immunol 95:536
48. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263
49. Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, Dayer J-M (1995) IL-10 inhibits metalloproteinase and stimulates TIMP-I production in human mononuclear phagocytes. J Clin Invest 96:2304
50. Lentsch AB, Shanley TP, Sarma V, Ward PA (1997) In vivo suppression of NF-κB and preservation of IκBα by interleukin-10 and interleukin-13. J Clin Invest 100:2443
51. Lewthwaite J, Blake SM, Hardingham TE, Warden PJ, Henderson B (1994) The effect of recombinant human interleukin-1 receptor antagonist on the induction phase of antigen induced arthritis in the rabbit. J Rheumatol 21:467
52. Li P, Allen H, Banerjee S, Franklin L, Herzog L, Johnston C, McDowell J, Paskind M, Rodman L, Salfeld J, Towne F, Tracey D, Warwell S, Wei F-Y, Wong W, Kamen R, Seshadri T (1995) Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80:401
53. Makarov SS, Olsen JC, Johnston WN, Anderle SK, Brown RR, Baldwin AS, Haskill JS, Schwab JH (1996) Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA. Proc Natl Acad Sci USA 93:402
54. Maksymowych WP, avina-Zubieta A, Luong M, Russel AS (1996) High dose intravenous immunoglobulin (IVIg) in severe refractory rheumatoid arthritis: no evidence for efficacy. Clin Exp Rheum 14:657
55. Malyak M, Swaney RE, Arend WP (1993) Levels of synovial fluid interleukin-1 receptor antagonist in rheumatoid arthritis and other arthropathies. Potential contribution from synovial fluid neutrophils. Arthritis Rheum 36:781
56. Malyak M, Smith MFJr, Abel AA, Arend WP (1994) Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1β. J Clin Immunol 14:20
57. Matsukawa A, Ohkawara S, Maeda T, Takagi K, Yoshinaga M (1993) Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits. Clin Exp Immunol 93:206
58. Miller LC, Lynch EA, Isa S, Logan JW, Dinarello CA, Steere AC (1993) Balance of synovial fluid IL-1β and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet 341:146
59. Muller-Ladner U, Roberts CR, Franklin BN, Gay RE, Robbins PD, Evans CH, Gay S (1997) Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective. J Immunol 158:3492
60. Neurath MF, Petterson S, Meyer zum Büschenfelde K-H, Stroher W (1996) Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nat Med 2:998
61. Nuki G, Rozman B, Pavelka K, Emery P, Lookabaugh J, Musikic P (1997) Interleukin-1 receptor antagonist continues to demonstrate clinical improvement in rheumatoid arthritis. Arthritis Rheum 40: S224
62. Otani K, Nita I, Macaulay W, Georgescu HI, Robbins PD, Evans CH (1996) Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy. J Immunol 156:3558
63. Overall CM, Wrana JL, Sodek J (1991) Transcriptional and posttranscriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-β1 in human fibroblasts. J Biol Chem 266:14064
64. Pettipher ER, Higgs GA, Henderson B (1986) Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci USA 83:8749
65. Rock CS, Coyle SM, Keogh CV, Lazarus DD, Hawes AS, Leskiw M, Moldawer LL, Stein TP, Lowry SF (1992) Influence of hypercortisolemia on the acute-phase protein response to endotoxin in humans. Surgery 112:467
66. Roessler BJ, Allen ED, Wilson JM, Hartman JW, Davidson BL (1993) Adenoviral-mediated gene transfer to rabbit synovium in vivo. J Clin Invest 92:1085
67. Roessler BJ, Hartman JW, Vallance DK, Latta JM, Janish SL, Davidson BL (1995) Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector. Hum Gene Ther 6:307
68. Roshak AK, Jackson JR, McGough K, Chabot-Fletcher M, Mochan E, Marshall LA (1996) Manipulation of distinct NFκB proteins alters interleukin-1β-induced human rheumatoid synovial fibroblast prostaglandin E2 formation. J Biol Chem 271:31496
69. Santos AA, Scheltinga MR, Lynch E, Brown EF, Lawton P, Chambers E, Browning J, Dinarello CA, Wolff SM, Wilmore DW (1993) Elaboration of interleukin 1-receptor antagonist is not attenuated by glucocorticoids after endotoxemia. Arch Surg 128:138
70. Satoh H, Chizzonite R, Ostrowski C, Ni-Wu G, Kim H, Fayer B, Mae N, Nadeau R, Liberato DJ (1994) Characterization of anti-IL-1α autoantibodies in the sera from healthy humans. Immunopharmacology 27:107
71. Scheimnan RI, Cogswell PC, Lofquist aK, Baldwin AS (1995) Role of transcriptional activation of IκBa in mediation of immunosuppression by glucocorticoids. Science 270:283
72. Schwab JH, Anderle SK, Brown RR, Dalldorf FG, Thompson RC (1991) Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. Infect Immun 59:4436
73. Seckinger P, Kaufmann M-T, Dayer J-M (1990) An interleukin-1 inhibitor affects both cell-associated interleukin-1-induced T cell proliferation and PGE2/collagenase production by human dermal fibroblasts and synovial cells. Immunobiology 180:316
74. Seckinger P, Klein-Nulend J, Alander C, Thompson RC, Dayer J-M, Raisz LG (1990) Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production. J Immunol 145:4181
75. Seckinger P, Yaron I, Meyer FA, Yaron M, Dayer J-M (1990) Modulation of the effects of interleukin-1 on glycosaminoglycan synthesis by the urine-derived interleukin-1 inhibitor, but not by interleukin-6. Arthritis Rheum 33:1807
76. Seitz M, Loetcher P, Dewald B, Towbin H, Rordorf C, Gallati H, Gerber NJ (1996) Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors. IL-1β, and IL-8: markers of remission in rheumatoid arthritis during treatment with methotrexate. J Rheumatol 23:1512
77. Shingu M, Fujikawa Y, Wada T, Nonaka S, Nobunaga M (1995) Increased IL-1 receptor antagonist (IL-1ra) production and decreased IL-1β/IL-1ra ratio in mononuclear cells from rheumatoid arthritis patients. Br J Rheumatol 34:24
78. Shiozawa S, Shiozawa K, Fujita T, Tokuhisa T (1992) Destructive arthritis without lymphocyte infiltration in H2-c-fos transgenic mice. J Immunol 148:3100
79. Shiozawa S, Shimizu K, Tanaka K, Hino K (1997) Studies on the contribution of c-fos/AP-1 to arthritic joint destruction. J Clin Invest 99: 1210
80. Smith RJ, Chin JE, Sam LM, Justen JM (1991) Biologic effects of an interleukin-1 receptor antagonist protein on interleukin-1-stimulated cartilage erosion and chondrocyte responsiveness. Arthritis Rheum 34:78
81. Stimpson SA, Dalldorf FG, Otterness IG, Schwab JH (1988) Exacerbation of arthritis by IL-1 in rat joints previously injured by peptidoglycan-polysaccharide. J Immunol 140:2964
82. Sugiyama E, Taki H, Kuroda A, Mino T, Yamashita N, Kobayashi M (1996) Interleukin-4 inhibits prostaglandin E2 production by freshly prepared adherent rheumatoid synovial cells via inhibition of biosynthesis and gene expression of cyclo-oxygenase II but not of cyclo-oxygenase I. Ann Rheum Dis 55:375
83. Svenson M, Hensen MB, Bendtzen K (1993) Binding of cytokines to pharmaceutically prepared human immunoglobulin. J Clin Invest 92:2533
84. Thornton S, Duwel LE, Hirsch R (1997) Course and severity of mouse collagen-induced arthritis is associated with distinct patterns of cytokine expression. Arthritis Rheum 40:S275
85. Van Roon JAG, van Roy JLAM, Gmelig-Meyling FHJ, Lafeber FPJG, Bijlsma JWJ (1996) Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 39:829
86. Walmsley M, Katsikis PD, Abney E, Parry S, Williams RO, Maini RN, Feldmann M (1995) Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum 39:495
87. Watson JM, Lofquist aK, Rinehart CA, Olsen JC, Makarov SS, Kaufman DG, Haskill JS (1995) The intracellular IL-1 receptor antagonist alters IL-1-inducible gene expression without blocking exogenous signaling by IL-1β. J Immunol 155:4467
88. Wooley PH, Whalen JD, Chapman DL, Burger AE, Richard KA, Aspar DG, Staite ND (1993) The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice. Arthritis Rheum 36:1305
89. Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV (1997) IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science 278:866
90. Yaswen L, Kulkarni AB, Fredrickson T, Mittleman B, Schiffman R, Payne S, Longenecker G, Mozes E, Karlson S (1996) Autoimmune manifestations in the transforming growth factor-beta I knockout mouse. Blood 87:1439